Yuhan Chen
Visiting MD/PhD Student
Last active: 9/11/2017

Yuhan Chen

Official Affiliation: Pharmacology

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Next-generation sequencing identifies pathogenic and modifier mutations in a consanguineous Chinese family with hypertrophic cardiomyopathy. Zhang X, Xie J, Zhu S, Chen Y, Wang L, Xu B (2017) Medicine (Baltimore) 96(24): e7010
    › Primary publication · 28614222 (PubMed) · PMC5478307 (PubMed Central)
  2. Exposure to particulate matter induces cardiomyocytes apoptosis after myocardial infarction through NFκB activation. Li X, Geng J, Chen Y, Chen F, Liu C, Xu Q, Zhao J, Hu J, Xie J, Xu B (2017) Biochem Biophys Res Commun 488(1): 224-231
    › Primary publication · 28499868 (PubMed)
  3. Percutaneous intervention versus coronary artery bypass graft surgery in left main coronary artery stenosis: a systematic review and meta-analysis. Zhang XL, Zhu QQ, Yang JJ, Chen YH, Li Y, Zhu SH, Xie J, Wang L, Kang LN, Xu B (2017) BMC Med 15(1): 84
    › Primary publication · 28427392 (PubMed) · PMC5399381 (PubMed Central)
  4. Cardiac repair in a mouse model of acute myocardial infarction with trophoblast stem cells. Li G, Chen J, Zhang X, He G, Tan W, Wu H, Li R, Chen Y, Gu R, Xie J, Xu B (2017) Sci Rep : 44376
    › Primary publication · 28295048 (PubMed) · PMC5353648 (PubMed Central)

Featured Affiliation

View all affiliations

Contact Information

No address provided
Email

Keywords & MeSH Terms

MeSH terms are retrieved from PubMed records. Learn more.

Key: MeSH Term Keyword

Adult Aged Asian Continental Ancestry Group Calcium Channels, L-Type Cardiac Myosins Cardiomyopathy, Hypertrophic, Familial Carrier Proteins Child China Consanguinity Coronary Artery Disease Coronary Stenosis Drug-Eluting Stents Echocardiography Female Genetic Association Studies Genetic Predisposition to Disease Genotyping Techniques Humans Incidence Male Middle Aged Mutation Myocardial Infarction Myosin Heavy Chains Proportional Hazards Models Sequence Analysis Stroke Treatment Outcome Young Adult